Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-29 @ 10:57 PM
Study NCT ID:
NCT06310304
Status:
COMPLETED
Last Update Posted:
2024-06-05
First Post:
2024-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2024-03-07
First Submit QC Date:
None
Study First Post Date:
2024-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-04
Last Update Post Date:
2024-06-05
Last Update Post Date Type:
ACTUAL